Cargando…
EGF Receptor-Targeting Cancer Therapy Using CD47-Engineered Cell-Derived Nanoplatforms
INTRODUCTION: Avoiding phagocytic cells and reducing off-target toxicity are the primary hurdles in the clinical application of nanoparticles containing therapeutics. For overcoming these errors, in this study, nanoparticles expressing CD47 proteins inhibiting the phagocytic attack of immune cells w...
Autores principales: | Choi, Moon Jung, Choi, Kang Chan, Lee, Do Hyun, Jeong, Hwa Yeon, Kang, Seong Jae, Kim, Min Woo, Jeong, In Ho, You, Young Myoung, Lee, Jin Suk, Lee, Yeon Kyung, Im, Chan Su, Park, Yong Serk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9270928/ https://www.ncbi.nlm.nih.gov/pubmed/35818431 http://dx.doi.org/10.2147/NSA.S352038 |
Ejemplares similares
-
Anti-EGF Receptor Aptamer-Guided Co-Delivery of Anti-Cancer siRNAs and Quantum Dots for Theranostics of Triple-Negative Breast Cancer
por: Kim, Min Woo, et al.
Publicado: (2019) -
Cancer-targeted Nucleic Acid Delivery and Quantum Dot Imaging Using EGF Receptor Aptamer-conjugated Lipid Nanoparticles
por: Kim, Min Woo, et al.
Publicado: (2017) -
Tumor-Targeted Erythrocyte Membrane Nanoparticles for Theranostics of Triple-Negative Breast Cancer
por: Choi, Moon Jung, et al.
Publicado: (2023) -
Tumor-specific delivery of therapeutic siRNAs by anti-EGFR immunonanoparticles
por: Kim, Jung Seok, et al.
Publicado: (2018) -
Versatile and Finely Tuned Albumin Nanoplatform based on Click Chemistry
por: Park, Ji Yong, et al.
Publicado: (2019)